New JerseyEffective Treatment Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Effective Treatment are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Suicide deaths among persons age 12 and over per 100,000 population 8.7 9.4 Achieved: 7% better
Adult hemodialysis patients with adequate dialysis - (Kt/V) 12 or higher 97.2 96.5 Achieved: 1% better
Short-stay home health patients who had diabetic foot care and patient education 98.6 98.6 0.0%
Stroke patients with educational material addressing activation of emergency medical system, follow-up after discharge, educations prescribed at discharge, risk factors for stroke, warning signs and symptoms of stroke 96.7 96.7 0.0%
Stroke patients who received venous thromboembolism (VTE) prophylaxis 97.7 98.7 1.1%
Acute stroke patients for whom IV thrombolytic therapy was initiated at hospital within 3 hours of time last known well 91.9 92.9 1.1%
Ratio of observed deaths to expected deaths among Medicare hemodialysis patients 0.9 0.9 1.2%
Stroke patients prescribed statin medication at hospital discharge 97.2 98.6 1.4%
Persons age 13 and over living with HIV who know their serostatus 90.3 91.9 1.7%
Women with clinical Stage I-IIb breast cancer who received axillary node dissection or sentinel lymph node biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy) 92.4 96.8 4.5%
Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment 90.9 95.4 4.8%
Patients with colon cancer who received surgical resection of colon cancer that included at least 12 lymph nodes pathologically examined 90.7 95.3 4.8%
Women under age 70 treated for breast cancer with breast-conserving surgery who received radiation therapy to the breast within 1 year of diagnosis 90.8 97.0 6.4%
Adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access 65.5 72.8 10.0%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Adults age 40 and over with diagnosed diabetes who received at least two hemoglobin A1c measurements in the calendar year 69.4 79.5 12.7%
Adults age 40 and over with diagnosed diabetes who received a dilated eye examination in the calendar year 65.1 75.2 13.4%
People age 12 and over treated for substance abuse who completed treatment course 53.8 65.2 17.5%
Breast cancer deaths per 100,000 female population per year 21.2 17.8 19.2%
Adults age 40 and over with diagnosed diabetes who had their feet checked for sores or irritation in the calendar year 65.8 84.0 21.7%
Adults age 40 and over with diagnosed diabetes who received a flu vaccination in the calendar year 51.3 65.8 22.1%
Lung cancer deaths per 100,000 population per year 33.8 27.5 23.1%
Colorectal cancer deaths per 100,000 population per year 14.5 11.5 25.6%
Dialysis patients who were registered on a waiting list for transplantation 18.6 28.2 34.0%
Adult end stage renal disease (ESRD) patients who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy 32.6 54.1 39.7%
Long-stay nursing home residents have depressive symptoms 1.6 1.1 43.5%
Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal failure 15.3 28.8 46.7%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Drug overdose deaths involving natural and semisynthetic opioids per 100,000 resident population 4.6 1.9 144.7%
HIV infection deaths per 100,000 population 2.2 0.8 193.3%
Hospital inpatient stays involving opioid-related diagnoses per 100,000 population 352.2 102.9 242.4%
New HIV cases per 100,000 population age 13 and over 15.4 4.2 266.7%
Emergency department visits involving opioid-related diagnoses per 100,000 population 334.4 65.2 412.5%
Drug overdose deaths involving any opioid per 100,000 resident population 22.0 4.0 444.6%
Drug overdose deaths involving other synthetic opioids (other than methadone) per 100,000 resident population 15.5 0.7 2023.3%
Measures With No Available Benchmark Information or Supplemental Measures
Measure Estimate Benchmark Distance to Benchmark
Radiation therapy was recommended or administered following any mastectomy within 1 year of diagnosis of breast cancer for women with 4 positive regional lymph nodes 85.7
Tamoxifen or third generation aromatase inhibitor was recommended or administered within 1 year of diagnosis for women with AJCC T1cN0M0 or stage IB to stage III hormone receptor-positive breast cancer 87.2
Median time in minutes outpatients with chest pain or possible heart attack who got drugs to break up blood clots after arrival 25.0
Median time in minutes before outpatients with chest pain or possible heart attack who needed specialized care were transferred to another hospital and did not have contraindication to fibrinolytic 73.0
Median time in minutes outpatients with chest pain or possible heart attack from emergency department arrival to get ECG 7.0
Outpatients with chest pain or possible heart attack who received fibrinolytic therapy within 30 minutes of arrival 80.2
Combination chemotherapy was recommended or administered within 4 months of diagnosis for women under 70 with AJCC T1cN0MO or Stage IB-III hormone receptor negative breast cancer 86.4
Use of brachytherapy in patients treated with primary radiation with curative intent in any stage of cervical cancer 73.2
Adjuvant chemotherapy was recommended or administered within 4 months of diagnosis for patients under the age of 80 with AJCC Stage III lymph node positive colon cancer 83.7
Composite measure: Cancer deaths per 100,000 population per year for all cancers 149.7
Radiation therapy was completed within 60 days of initiation of radiation among women diagnosed with any stage of cervical cancer 65.5
Patients who came to the emergency department (ED) with stroke symptoms and received head CT or MRI who received the interpretation of the results within 45 minutes of ED arrival 77.7
Percent of hemodialysis patients whose hemoglobin level is less than 10 g/dL 16.4
New AIDS cases per 100,000 population age 13 and over 8.5
Patients with end stage renal disease due to diabetes 41.6